PI
MRNA icon

PEAK6 Investments’s Moderna MRNA Stock Holding History

PEAK6 Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.45M Sell
51,611
-43,585
-46% -$4M 0.01% 1158
2024
Q2 		$11.3M Buy
95,196
+43,591
+84% +$5.52M 0.03% 446
2024
Q1 		$5.5M Sell
51,605
-60,333
-54% -$6.08M 0.01% 776
2023
Q4 		$11.1M Buy
+111,938
New +$9.41M 0.04% 437
2023
Q2 		– Sell
-4
Closed -$534 – 4398
2023
Q1 		$594 Sell
4
-54,667
-100% -$9.02M ﹤0.01% 4134
2022
Q4 		$9.82M Buy
54,671
+50,411
+1,183% +$8.24M 0.06% 382
2022
Q3 		$504K Sell
4,260
-78,095
-95% -$11.8M ﹤0.01% 2861
2022
Q2 		$11.8M Sell
82,355
-203,735
-71% -$29.1M 0.02% 763
2022
Q1 		$49.3M Buy
286,090
+15,153
+6% +$2.55M 0.1% 163
2021
Q4 		$68.8M Buy
270,937
+156,151
+136% +$45.7M 0.15% 121
2021
Q3 		$44.2M Buy
114,786
+74,488
+185% +$27.5M 0.1% 173
2021
Q2 		$9.47M Sell
40,298
-14,850
-27% -$2.65M 0.02% 723
2021
Q1 		$7.22M Buy
55,148
+35,900
+187% +$5.2M 0.02% 804
2020
Q4 		$2.01M Buy
+19,248
New +$1.95M ﹤0.01% 1843

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PEAK6 Investments's MRNA Position: Q3 2024 in Review

PEAK6 Investments reduced its Moderna (MRNA) stake by 46% in Q3 2024, selling an estimated $4M and leaving 51,611 shares worth $3.45M. The position accounts for 0.01% of the portfolio, ranked #1158.

PEAK6 Investments first reported a position in MRNA in Q4 2020 and has held it in 14 quarters since. The position peaked at $68.8M in Q4 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • PEAK6 Investments held 51,611 shares of Moderna worth $3.45M as of Q3 2024.
  • PEAK6 Investments sold 43,585 Moderna shares in Q3 2024, an estimated $4M.
  • Moderna made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1158 holding.
  • PEAK6 Investments first reported a position in Moderna in Q4 2020 and has held it in 14 quarters since.
  • PEAK6 Investments's Moderna position peaked at $68.8M in Q4 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.